Detalles de la búsqueda
1.
Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group.
J Clin Oncol
; 30(20): 2545-51, 2012 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22665540
Resultados
1 -
1
de 1
1
Próxima >
>>